Mode
Text Size
Log in / Sign up
N/A Completed N=90 Treatment

Stroke and CPAP Outcome Study 2

Sleep Apnea, Obstructive · Stroke · Patient Adherence
Source: ClinicalTrials.gov NCT02809430 ↗
Enrolled (actual)
90
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcomePrimary: 3-month CPAP Adherence — 32 participants adherent to CPAP at 90 days

Summary

Obstructive sleep apnea (OSA) is associated with impaired stroke recovery. Treatment with continuous positive airway pressure (CPAP) may prevent this but is limited by poor adherence. In this study, the investigators enrolled eligible stroke patients undergoing inpatient rehabilitation (IPR) into an intensive CPAP adherence protocol (iCAP) with an aim to increase tolerance and adherence to auto-titrating CPAP (APAP).

Outcome Measures

OutcomeResultp-value
PRIMARY
3-month CPAP Adherence
32
SECONDARY
CPAP Tolerance
52
SECONDARY
Change in the Cognitive Functional Independence Measure (FIM) Subscore
8.2; 4.6
SECONDARY
Change in the Motor Functional Independence Measure (FIM) Subscore
31.2; 30.2
SECONDARY
Change in NIH Stroke Scale
-3.8; -1.6

Eligibility Criteria

Inclusion Criteria

  • Adult patients admitted after acute ischemic or hemorrhagic stroke to one of two inpatient rehabilitation units

Exclusion Criteria

  • The investigators will exclude participants if: their stroke was a subarachnoid hemorrhage or due to a secondary cause (vascular malformation, vasculitis, brain tumor, head trauma, or predisposition to bleeding); they have active CPAP use, advanced chronic lung disease requiring supplemental oxygen, heart failure (NYHA class III or IV); or they needed a nasogastric feeding tube.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02809430). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search